Our preliminary studies show that our products are effective using a very small fraction of the active pharmaceutical ingredients required in systemic administration for similar periods. Our localized medication is essential in many treatment regimens, such as the treatment of infections, inflammation and certain cancers.
PolyPid’s PLEX targeted drug delivery platform enables localized, controlled, continuous release of medication over prolonged periods of time for better patient outcomes.
Read More >
Is designed to prevent the risk of surgical site infections in both bone and soft tissue through its cutting-edge, local, extended-release mechanism
Read More >
Comprised of antibiotic eluting ß tri-calcium phosphate (ßTCP) granules, designed for bone related infections applications.
Read More >